Brought to you by 
Small Molecule Therapeutics raises $8mm in second round
13 Jul 1999
Executive Summary
Small Molecule Therapeutics (proteomics) raised $8mm in its second venture round, selling over 5mm shares at $1.50 each. Its pre-money valuation was $9.975mm; post-money is $17.97mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Small Molecule Therapeutics raises $8mm in second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice